Shenyang Xingqi Pharmaceutical Co.,Ltd.

300573

CNE100002DV1

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 03:30:00 28/05/2024 am IST			5-day change	1st Jan Change
196.9 ^CNY	+1.94%		-1.59%	+51.22%

22/05	Space Peptides announced that it has received funding from Humanwell Healthcare Co.,Ltd., Shenyang Xingqi Pharmaceutical Co.,Ltd., Xiamen Furuier Pharmaceutical Co., Ltd., Purple Knight Capital and other investors	CI
15/05	Shenyang Xingqi Pharmaceutical Co.,Ltd. Announces Cash Dividend for 2023, Payable May 22, 2024	CI

Shenyang Xingqi Pharmaceutical Co.,Ltd. Announces Cash Dividend for 2023, Payable May 22, 2024

May 16, 2024 at 01:02 am IST

Shenyang Xingqi Pharmaceutical Co.,Ltd. announced 2023 final profit distribution plan to be implemented (A shares): Cash dividend per 10 shares (tax included): CNY 30.00000000. Record date: 21 May 2024, Ex-date: 22 May 2024. Payment date: 22 May 2024.

Latest news about Shenyang Xingqi Pharmaceutical Co.,Ltd.

Space Peptides announced that it has received funding from Humanwell Healthcare Co.,Ltd., Shenyang Xingqi Pharmaceutical Co.,Ltd., Xiamen Furuier Pharmaceutical Co., Ltd., Purple Knight Capital and other investors	22/05	CI
Shenyang Xingqi Pharmaceutical Co.,Ltd. Announces Cash Dividend for 2023, Payable May 22, 2024	16/05	CI
Shenyang Xingqi Pharmaceutical's Q1 Profit Jumps 80%	26/04	MT
Shenyang Xingqi Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	25/04	CI
Shenyang Xingqi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	18/04	CI
Xingqi Pharma Gets Nod to Market Atropine Sulfate Eye Drop; Shares Up 3%	13/03	MT
Shenyang Xingqi Pharmaceutical Co.,Ltd. Approves Board Elections	09/01	CI
Shenyang Xingqi Pharmaceutical Co.,Ltd.(SZSE:300573) added to Shenzhen Stock Exchange Component Index	12/12	CI
Shenyang Xingqi Pharmaceutical Co.,Ltd.(SZSE:300573) added to Shenzhen Stock Exchange Component A Share Index	12/12	CI
Xingqi Pharmaceutical's Diquafosol Sodium Eye Drops Bags China's Centralized Drug Bid	08/11	MT
Shenyang Xingqi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23/23/23	CI
Shenyang Xingqi Pharmaceutical Co.,Ltd. Announces Interim Dividend on A Shares for the Year 2023, Payable on 22 September 2023	19/23/19	CI
Shenyang Xingqi Pharmaceutical Co.,Ltd Approves Cash Interim Profit Distribution Plan for 2023	15/23/15	CI
Shenyang Xingqi Pharmaceutical Co.,Ltd. Proposes Interim Dividend for the First Half of 2023	30/23/30	CI
Shenyang Xingqi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	28/23/28	CI
Xingqi Pharmaceutical Enrolls First Subject for Phase 4 Trial of Eye Drops	17/23/17	MT
Shenyang Xingqi Pharmaceutical Co.,Ltd Approves Cash Dividend for the Year 2022, Payable on 22 May 2023	13/23/13	CI
Shenyang Xingqi Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	26/23/26	CI
Shenyang Xingqi Pharmaceutical Co.,Ltd Proposes Final Dividend for 2022	21/23/21	CI
Shenyang Xingqi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	19/23/19	CI
Shenyang Xingqi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	26/22/26	CI
Shenyang Xingqi Pharmaceutical Co.,Ltd Announces Interim Dividend on A Shares for the Year 2021, Payable on September 23, 2022	17/22/17	CI
Shenyang Xingqi Pharmaceutical Co.,Ltd Approves Interim Cash Dividend for 2022	15/22/15	CI
Shenyang Xingqi Pharmaceutical Announces Profit Distribution Proposal for the First Half of 2022	29/22/29	CI
Shenyang Xingqi Pharmaceutical Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2022	28/22/28	CI

Chart Shenyang Xingqi Pharmaceutical Co.,Ltd.

Duration

Period

Chart Shenyang Xingqi Pharmaceutical Co.,Ltd.

More charts

Company Profile

SHENYANG XINGQI PHARMACEUTICAL CO., LTD. is a China-based company principally engaged in the research, development, manufacture and distribution of ophthalmic drugs. The Companyâs main products are ophthalmic prescription drugs, including corneal repairing drugs, anti-bacteria drugs, artificial tears, anti-inflammation drugs, anti-allergic drugs, as well as anti-hyperemia & fatigue relief drugs and others. The Company mainly distributes its products within domestic market.

Sector

Pharmaceuticals

Calendar

28/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Shenyang Xingqi Pharmaceutical Co.,Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

196.9

Average target price

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Specialty & Advanced Pharmaceuticals

	1st Jan change	Capi.
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.	+51.22%	4.74B
MERCK KGAA	+17.45%	79.28B
KYOWA KIRIN CO. LTD.	+7.97%	8.74B
SK BIOPHARMACEUTICALS CO., LTD.	-16.33%	4.84B
YUHAN CORPORATION	+2.18%	3.87B
INDIVIOR PLC	+21.20%	2.46B
BETTA PHARMACEUTICALS CO., LTD.	-26.79%	2.18B
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.	+15.12%	2.09B
CHANGCHUN BCHT BIOTECHNOLOGY CO.	-36.56%	1.98B
VELOXIS PHARMACEUTICALS A/S	-0.50%	1.64B

Specialty & Advanced Pharmaceuticals